Kyntra Bio KYNB
NASDAQ KYNB
$3.24 -0.25 (-7.13%)
As of: Nov 16, 2026 · 1:55 PM EST

Kyntra Bio (KYNB) Short term Debt (2013 - 2025)

Updated

Kyntra Bio (KYNB) posted Short term Debt of $73.73 million for Q2 2025.

Analysis

Kyntra Bio (KYNB) Short term Debt (2013 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,286.98 Bn 1,260.60 Bn 20.46 Bn
2 Johnson & Johnson 685.09 Bn 604.95 Bn 17.30 Bn
3 AbbVie 523.41 Bn 491.42 Bn 13.12 Bn
4 Merck 361.33 Bn 324.27 Bn 13.19 Bn
5 Novartis Ag 312.92 Bn 286.15 Bn -
6 Astrazeneca 286.64 Bn 260.16 Bn 13.26 Bn
7 Amgen 252.19 Bn 203.84 Bn 7.58 Bn
8 Gilead Sciences 209.51 Bn 184.62 Bn 6.73 Bn
9 Pfizer 165.21 Bn 112.57 Bn 12.56 Bn
10 Kyntra Bio 13.14 Mn -394.81 Mn 1.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -75.00 Mn
Sep 30, 2025 -75.00 Mn
Jun 30, 2025 73.73 Mn
Sep 30, 2023 -2.75 Mn
Jun 30, 2023 -2.75 Mn
Dec 31, 2014 403,000.00
Dec 31, 2013 403,000.00
API Access

Kyntra Bio Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=KYNB&period=max&api_key=YOUR_API_KEY